#United States #NASDAQ #San Mateo #pharmaceuticals #Talphera

Talphera to Report Third Quarter Financial Results

Talphera, Inc. (Nasdaq: TLPH), a specialty pharmaceutical company dedicated to developing innovative therapies for clinically supervised environments, has announced that it will hold a conference call and webcast on November 12, 2026, at 4:30 PM Eastern Time (1:30 PM Pacific Time). During this event, the company will discuss the financial outcomes for the third quarter ending September 30, 2026, alongside recent advancements in its business strategies.

Event Details

Participants can join the call by dialing in via the following numbers:

• - North America: 1-800-836-8184
• - International: 1-646-357-8785

Conference ID: 69368

Additionally, the event can be accessed through a webcast on the Talphera website under the Investors section. Following the live event, a replay of the webcast will be available on the site for a duration of 90 days.

About Talphera, Inc.

Founded with a focus on healthcare innovation, Talphera has carved a niche in the pharmaceutical market, developing solutions that address specific medical needs in controlled environments. Their flagship product candidate, Niyad®, is a lyophilized form of nafamostat, currently undergoing studies as part of an FDA investigational device exemption (IDE) for use as an anticoagulant within extracorporeal circuits. Notably, nafamostat was granted Breakthrough Device Designation by the FDA, indicating its potential to significantly advance medical treatment.

Talphera’s commitment to research and development continues to shape its trajectory in enhancing patient care and providing healthcare professionals with cutting-edge solutions. The upcoming financial results conference aims to shed light on the company’s recent progress and future plans.

As a company deeply invested in advancing medical therapies, Talphera invites current and potential investors to participate in this announcement that not only reflects financial metrics but also underscores the impact of their innovative products in the healthcare landscape.

For more information about Talphera and to join the conference call, you can visit their official website at www.talphera.com.